Furthermore, it was reported that treatment with PPARα agonist WY-14643 induces peroxisomal fatty acid oxidation and inhibits ethanol-induced hepatic steatosis in mice (Xu et al. 2022). This evidence concerns the gene PPARA and fatty liver disease.